Capital International Investors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-44,300
Closed -$2.58M 453
2023
Q2
$2.58M Hold
44,300
﹤0.01% 422
2023
Q1
$2.74M Sell
44,300
-27,799
-39% -$1.67M ﹤0.01% 421
2022
Q4
$4.58M Sell
72,099
-2,851,963
-98% -$207M ﹤0.01% 406
2022
Q3
$212M Buy
2,924,062
+4,998
+0.2% +$372K 0.06% 231
2022
Q2
$198M Buy
2,919,064
+81,019
+3% +$5.82M 0.05% 245
2022
Q1
$257M Buy
2,838,045
+22,159
+0.8% +$1.81M 0.06% 238
2021
Q4
$257M Buy
2,815,886
+338,948
+14% +$29M 0.05% 243
2021
Q3
$201M Buy
2,476,938
+1,964,888
+384% +$165M 0.05% 248
2021
Q2
$47.8M Buy
512,050
+62,050
+14% +$6.01M 0.01% 363
2021
Q1
$48.1M Hold
450,000
0.01% 338
2020
Q4
$39.3M Hold
450,000
0.01% 349
2020
Q3
$31.1M Hold
450,000
0.01% 346
2020
Q2
$21.8M Buy
+450,000
New +$21.5M 0.01% 347

Other funds holding NARI

Capital International Investors's NARI Position: Q3 2023 in Review

Capital International Investors sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2023, closing a stake of 44,300 shares — an estimated $2.58M sold.

Capital International Investors first reported a position in NARI in Q2 2020 and held it in 13 quarters. The position peaked at $257M in Q1 2022. 250 funds tracked by Wall St. Rank hold NARI as of Q3 2023.

  • Capital International Investors reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Capital International Investors sold 44,300 Inari Medical, Inc. Common Stock shares in Q3 2023, an estimated $2.58M.
  • Capital International Investors first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 13 quarters.
  • Capital International Investors's Inari Medical, Inc. Common Stock position peaked at $257M in Q1 2022.
  • 250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2023.

Based on Capital International Investors's 13F filing for Q3 2023, filed 13 Nov 2023.